The mRNA method is projected to be a game-changer in the development of vaccines against several infectious diseases. — Bloomberg
Germany's BioNTech and American pharmaceutical giant Pfizer, which together developed the first approved Covid-19 vaccine, said on Jan 5 (2022) that they are working on a shingles shot using the same mRNA (messenger ribonucleic acid) technology.
Meanwhile, American biotechnology company Moderna announced it had dosed its first volunteer for a vaccine against Epstein-Barr virus (EBV), the cause of mononucleosis.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
